4Vote!
MarketIntelligenceCenter.com (Free subscription) | 8 hours ago
T Rowe Price (TROW) was upgraded today by analysts at Credit Suisse and the stock is now at $51.59, up $1.01 (2%) on volume of 1,772,812 shares traded. The stock is moving higher today after Credit Suisse upgraded the stock to Outperform from Neutral. Over the last 52 weeks the stock has ranged from a low of $20.09 in March to a high of $55.48 last month. T Rowe Price stock has been showin...
5Vote!
Market Wire (Free subscription) | 2 hours ago
HOUSTON, TX (MARKET WIRE) Mariner Energy, Inc. (NYSE: ME) announced today that Scott D. Josey, Chairman, Chief Executive Officer and President, will present at the Credit Suisse 2009 Vertical Tour in Houston on Thursday, November 12, 2009 at 10:15 a.m., Central Time. While presentations at this conference will not be webcast, a PDF version of Mariner's presentation materials will be accessible...
+Vote!
Tech Trader Daily (Free subscription) | 8 hours ago
Priceline (PCLN) shares are trading lower today after Credit Suisse analyst Scott Barry cut his rating on the stock to Neutral from Outperform, while increasing his target to $210, from $185. PCLN yesterday closed at $204.22, up $30.49, or 17.6%, after a better-than-expected Q3 earnings report. Barry writes that the company [...]
4Vote!
The Earth Times Online Newspaper (Free subscription) | yesterday
MORRISTOWN, N.J., Nov. 10 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today a change for the Company's presentation at the Credit Suisse 18th Annual Healthcare Conference scheduled for Wednesday, November ...
4Vote!
Business Wire (Free subscription) | yesterday
CAMBRIDGE, Mass.--(BUSINESS WIRE)--First graph, first sentence of release dated November 9, 2009, should read: ...Friday, November 13, 2009 at 8:30 a.m. MST, 10:30 a.m. EST. (sted ...Friday, November 13, 2009 at 8:30 a.m. MST, 6:30 a.m. EST.). The corrected release reads: BIOGEN IDEC TO PRESENT AT THE 2009 ANNUAL CREDIT SUISSE HEALTHCARE CONFERENCE Biogen Idec Inc. (NASDAQ:BIIB) announced today...
4Vote!
PR News Wire (Free subscription) | yesterday
MORRISTOWN, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today a change for the Company's presentation at the Credit Suisse 18th Annual Healthcare Conference scheduled for Wednesday, November 11, 2009. Watson's presentation will take place at 11:00 a.m. Eastern Standard Time.
4Vote!
MarketIntelligenceCenter.com (Free subscription) | yesterday
Credit Suisse Group (NYSE: CS) closed yesterday at $58.62. So far the stock has hit a 52-week low of $18.61 and 52-week high of $60.08. Credit Suisse Group stock has been showing support around 56.45 and resistance in the 59.81 range. Technical indicators for the stock are Bullish and S&P gives CS a positive 4 STAR (out of 5) buy rating. CS appears on the Investors Observer Hedged...
4Vote!
PR News Wire (Free subscription) | yesterday
PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Credit Suisse Healthcare Conference on Thursday, November 12, 2009 at 1:00 p.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.
4Vote!
Business Wire (Free subscription) | yesterday
HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Credit Suisse 18th Annual Healthcare Conference on Friday, November 13th, at 10:00 a.m. Mountain Standard time. The conference will be held at the Arizona Biltmore Hotel located in Phoenix, AZ. Individuals may listen to the live or an archived presentation made at the...
4Vote!
Business Wire (Free subscription) | yesterday
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will present at a Credit Suisse healthcare conference on Thursday, November 12, 2009 in Phoenix, Arizona. Jean-Marc Huet, executive vice president and chief financial officer of Bristol-Myers Squibb, will make a formal presentation about the company at 10:30 a.m. ET. Investors and the general public are invited to listen to a...
4Vote!
MarketIntelligenceCenter.com (Free subscription) | 11/09/2009
Credit Suisse Group (NYSE: CS) ended the last trading session at $55.68. So far the stock has hit a 52-week low of $18.61 and 52-week high of $60.08. Credit Suisse Group stock has been showing support around 54.12 and resistance in the 56.80 range. Technical indicators for the stock are Bullish and S&P gives CS a positive 4 STAR (out of 5) buy rating. CS appears on the Investors Observer...
4Vote!
Market Watch (Free subscription) | yesterday
LONDON (MarketWatch) -- Credit Suisse upgraded its stance on Continental Europe to 5% overweight from 5% underweight on Tuesday, the first time it has been overweight on the region since 2007. The broker said that Europe typically starts to outperform nine months after a trough in global lead indicators and when interest rate expectations start to rise. In addition, indicators suggest the same...
4Vote!
PR News Wire (Free subscription) | yesterday
BOSTON, Nov. 10 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Credit Suisse 18th Annual Healthcare Conference in Phoenix, AZ. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a formal presentation on PAREXEL at 12:00 p.m. EST on Friday, November 13, 2009.
3Vote!
virtualreview: china|blogs (Free subscription) | 11/09/2009
WSJ's Jason Dean speaks to Zhang Liping, head of Credit Suisse's China Investment Banking Department, about how the recession has affected the financial-services group in China. Zhang also shares his views on future trends in Chinese M&A.
4Vote!
Business Wire (Free subscription) | 11/09/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the 2009 Annual Credit Suisse Healthcare Conference will be webcast live via the internet, on Friday, November 13, 2009 at 8:30 a.m. MST, 6:30 a.m. EST. To access the live webcast, please visit Biogen Idec’s Investor Relations section (investor.biogenidec.com). An archived version...
